Skip to main content

Advertisement

SpringerLink
Log in

Endovascular surgery in the field of ophthalmology

  • Forefront Review
  • Organizer: Hiroyuki Iijima, MD
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

In this article, we provide an overview of the current perspectives on endovascular surgery in ophthalmology, including a description of the various approaches, recent clinical results and future prospects. Experimental studies of endovascular surgery in ophthalmology started in the 1980s; since then, a considerable amount of research has been done to develop the procedure for clinical use. During the past two decades endovascular surgery has been performed on eyes with retinal vascular disorders, including central retinal vein occlusion and central retinal artery occlusion. The first endovascular surgery on human eyes was performed in 1998 on a patient with central retinal vein occlusion (CRVO). The most recent techniques used in retinal endovascular surgery involve manual injection of liquid agents such as tissue plasminogen activator into major retinal vessels using a 47 or 48-gauge micro-needle. New technology using a bimanual procedure and digitally assisted vitrectomy systems enables surgeons to perform this delicate procedure more effectively. Recent results reported from a number of researchers corroborate the effectiveness of the procedure. Endovascular surgery is one of the latest techniques in the field of ophthalmology and has garnered significant interest from vitreoretinal surgeons. However, it is also at the limit of what surgeons are able to accomplish with manual precision. There is still much to learn and improve to maximize the potential of this approach. The combination of skills as a surgeon, sound science, objective clinical evidence and cutting edge technology will lead to improvements in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hattenbach LO, Puchta J, Hilgenberg I. Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion. Invest Ophthalmol Vis Sci. 2012;53:42–6.

    Article  Google Scholar 

  2. Pournaras CJ, Petropoulos IK, Pournaras JA, Stangos AN, Gilodi N, Rungger-Brändle E. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application. Retina. 2012;32:1566–73.

    Article  Google Scholar 

  3. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1:27–55.

    CAS  PubMed  Google Scholar 

  4. Hayreh SS, Zimmerman MB. Central retinal arterial occlusion: visual outcome. Am J Ophthalmol. 2005a;140:376–91.

    Article  Google Scholar 

  5. Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology. 1982;89:14–9.

    Article  CAS  Google Scholar 

  6. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol. 1998;126:142–4.

    Article  CAS  Google Scholar 

  7. Bynoe LA, Huchins RK, Lazarus HS, Friedberg MA. Retinal endovascular surgery for central retinal vein occlusion. Retina. 2005;25:625–32.

    Article  Google Scholar 

  8. Eckardt C, Paulo EB. Heads-up surgery for vitreoretinal procedures: an experimental and clinical study. Retina. 2016;36:137–47.

    Article  Google Scholar 

  9. Ishida M, Abe S, Nakagawa T, Hayashi A. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2017;255:2135–40.

    Article  CAS  Google Scholar 

  10. Hayreh SS, Zimmerman B. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005b;140:376–91.

    Article  Google Scholar 

  11. Urbaniak J. Hand clinics, microvascular surgery. Philadelphia: Saunders; 1985. p. 98–134.

    Google Scholar 

  12. Andreucci VE. Manual of renal micropuncture. Naples: Idelson; 1978. p. 32–4.

    Google Scholar 

  13. Ashton N. Injection of the retinal vascular system in the enucleated eye in diabetic retinopathy. Br J Ophthalmol. 1950;34:38–41.

    Article  CAS  Google Scholar 

  14. Allf BE, de Juan E. In vivo cannulation of retinal vessels. Graefes Arch Clin Exp Ophthalmol. 1987;225:221–5.

    Article  CAS  Google Scholar 

  15. Suzuki Y, Matsuhashi H, Nakazawa M. In vivo retinal vascular cannulation in rabbits. Graefes Arch Clin Exp Ophthalmol. 2003;241:585–8.

    Article  Google Scholar 

  16. Tameesh MK, Lakhanpal RR, Fujii GY, Javaheri M, Shelley TH, Danna S, et al. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol. 2004;138:829–39.

    Article  CAS  Google Scholar 

  17. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105–12.

    Article  Google Scholar 

  18. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56:581–7.

    Article  CAS  Google Scholar 

  19. McAllister DV, Wang PM, Davis SP. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA. 2003;100:13755–60.

    Article  CAS  Google Scholar 

  20. Kadonosono K, Arakawa A, Yamane S, Uchio E, Yanagi Y. An experimental study of retinal endovascular surgery with a microfabricated needle. Invest Ophthalmol Vis Sci. 2011;52:5790–3.

    Article  Google Scholar 

  21. Gijbels A, Smits J, Schoevaerdts L, Willekens K, Vander Poorten EB, Stalmans P, et al. In-human robot-assisted retinal vein cannulation, a world first. Ann Biomed Eng. 2018;46:1676–85.

    Article  Google Scholar 

  22. de Smet MD, Meenink TC, Janssens T, Vanheukelom V, Naus GJ, Beelen MJ, et al. Robotic assisted cannulation of occluded retinal veins. PLoS ONE. 2016;11(9):e0162037.

    Article  Google Scholar 

  23. Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, et al. Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study. Am J Ophthalmol. 2014;158:1032–8.

    Article  CAS  Google Scholar 

  24. Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ, et al. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology. 2014;121:1414–20.

    Article  Google Scholar 

  25. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1124–33.

    Article  Google Scholar 

  26. Larsen M, Waldstein SM, Boscia F, Gerding H, Monés J, Tadayoni R, CRYSTAL Study Group, et al. Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion. Twelve-month results of the CRYSTAL study. Ophthalmology. 2016;123:1101–11.

    Article  Google Scholar 

  27. Kadonosono K, Yamane S, Arakawa A, Inoue M, Yamakawa T, Uchio E, et al. Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol. 2013;131:783–6.

    Article  Google Scholar 

  28. Gombos GM. Anterior chamber paracentesis and carbogen treatment of acute CRAO. Ophthalmology. 1996;103:865.

    Article  CAS  Google Scholar 

  29. Youn TS, Lavin P, Patrylo M, Schindler J, Kirshner H, Greer DM, et al. Current treatment of central retinal artery occlusion: a national survey. J Neurol. 2018;265:330–5.

    Article  Google Scholar 

  30. Watanabe I, Miyake Y, Ando F, Sakakibara K, Sakakibara B. The effect of hyperbaric oxygen on ERG. Nippon Ganka Gakkai Zasshi. 1969;73:1920–33 (in Japanese).

    CAS  PubMed  Google Scholar 

  31. Kadonosono K, Yamane S, Inoue M, Yamakawa T, Uchio E. Intra-retinal arterial cannulation using a microneedle for central retinal artery occlusion. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-19747-7.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Takata Y, Nitta Y, Miyakoshi A, Hayashi A. Retinal endovascular surgery with tissue plasminogen activator injection for central retinal artery occlusion. Case Rep Ophthalmol. 2018;22(9):327–32.

    Article  Google Scholar 

  33. Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007;27:215–30.

    Article  Google Scholar 

  34. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol. 2002;120:1234–6.

    Article  Google Scholar 

  35. Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol. 2015;72:1148–54.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Micro-Technology, Yokohama City University, 4-57 Urafune-cho Minami-ku, Yokohama, 232-0024, Japan

    Kazuaki Kadonosono

  2. Department of Ophthalmology, University of Toyama, Toyama, Japan

    Atsushi Hayashi

  3. Department of Ophthalmology, University of California, San Francisco, USA

    Eugene de Juan Jr.

Authors
  1. Kazuaki Kadonosono
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atsushi Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugene de Juan Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuaki Kadonosono.

Ethics declarations

Conflicts of interest

K. Kadonosono, None; A. Hayashi, None; E. D. Juan Jr., None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Organizer: Hiroyuki Iijima, MD.

Corresponding Author: Kazuaki Kadonosono

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (MP4 43112 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kadonosono, K., Hayashi, A. & de Juan, E. Endovascular surgery in the field of ophthalmology. Jpn J Ophthalmol 65, 1–5 (2021). https://doi.org/10.1007/s10384-020-00776-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-020-00776-7

Keywords

Search

Navigation